Anti-TNBC agent-1
Anti-TNBC agent-1 is a potent anti-triple-negative breast cancer (TNBC) agent. anti-TNBC agent-1 exhibits potent activity against different breast cancer cells with IC50 values ranging from 0.20 μM to 0.27 μM. anti-TNBC agent-1 induces apoptosis of SUM-159 cells through mitochondria pathway and causes G1 phase arrest of SUM-159 cells[1].
Product Specifications
CAS Number
2289585-58-4
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anti-tnbc-agent-1.html
Purity
98.02
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
C[C@@]1(CC/C=C2COC(/C=C/C(C(OC)=CC=C3)=C3OC)=O)[C@@](O1)([H])[C@](OC4=O)([H])[C@](CC/2)([H])C4=C
Molecular Formula
C26H30O7
Molecular Weight
454.51
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
3,3',4,4',5,5'-Hexabromo-2,2'-diaminebiphenyl
PAFAH (PLA2G7) (NM_001168357) Human Recombinant Protein
